Local site sets a new benchmark for the fragrance industry(BUSINESS WIRE) -- IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences, announced the installation of a nature-based hydrogen production facility at its Scent R&D and fragrance ingredients manufacturing plant in Benicarló, Spain. The site has partnered with Iberdrola, one of the world’s largest producers of renewable energy, to become the first in the fragrance industry to rely on renewable electricity for hydrogenation reactions used in manufacturing key fragrance ingredients. Aligned with the company’s commitment to Do More Good for people and planet, the site’s system can make 100 tons of clean hydrogen annually using renewable energy. It includes a built-in compressor to store hydrogen on-site — reducing the Life Cycle Assessment (LCA) of its products and supporting customers worldwide in achieving their decarbonization goals.“The Benicarló site’s new hydrogen production capability is a ... Read more »

New digital documentation system designed to provide richer experience, always-current installation guides, and localization for installers around the world

(BUSINESS WIRE) -- Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today unveiled a comprehensive upgrade to the way the Company supports solar installers with product documentation during the installation process. Beginning in November 2025, new Tigo TS4 Flex MLPE product shipments will replace printed installation manuals with digital documentation accessible via QR codes prominently displayed directly on each product box. The change to digital documentation gives installers instant access to the most current installation guides, immersive visual guides and videos, and localization for languages in the markets Tigo serves.

In the spirit of Total Quality Solar (TQS) and on the heels of the Green Glove service program and the Tigo Academ ... Read more »

JERSEY CITY, N.J. - Friday, 07. November 2025 AETOSWire Net proceeds will be applied to debt reduction, advancing Organon’s ongoing deleveraging efforts Positions Organon for future investment in growth opportunities with a focus on women’s health biopharma and other strategic priorities Laborie’s capabilities in medical technology will facilitate broader access to JADA for more mothers (BUSINESS WIRE)--Organon (NYSE: OGN), (“Organon” or “the Company”) a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has entered into an agreement with Laborie Medical Technologies Corp. (“Laborie”), a leading diagnostic and therapeutic medical technology company, for them to acquire the JADA System. The transaction, valued at up to $465 million, is comprised of $440 million to be paid at closing, subject to certain closing adjustments, and a potential payment of up to $25 million subject to the achievement of ... Read more »

PRINCETON, N.J. - Friday, 07. November 2025 AETOSWire


(BUSINESS WIRE)--NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and full integration of the research services of L2P Research Labs® (“Lab to Pharmacy”), further expanding its service portfolio, and bridging the translational research gap.

Currently, the attrition rate of biological molecules moving past phase 1 clinical trials is very high and the way to overcome this challenge is through translational research. NJ Bio specializes in preclinical and early-phase clinical research and development, with a primary focus on ADCs, bioconjugation, custom synthesis, oligonucleotides, and mRNAs. However, there was a gap in providing translational research services to its clients. With the asset purchase and integration of L2P ’s services, NJ Bio can now offer a comprehensive suite of pre-clinical and translational research s ... Read more »